What You Should Know:
- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced it has secured a debt facility of up to $80M with Hercules Capital, Inc. and Silicon Valley Bank.
- Lucira's COVID-19 testing platform produces lab-quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. The FDA EUA
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials
What You Should Know:
- Today, Twist Bioscience and cancer genomics startup C2i Genomics announced a partnership to develop whole-genome cancer reference materials.
- This resource will provide diagnostic labs around the globe with the ability to better validate and monitor the quality of their whole-genome cancer screening and minimal residual disease (MRD) products for more accurate cancer detection.
C2i to integrate Twist’s library preparation kits into minimal residual
Read More
CVS Health Taps Medable to Bring Decentralized Clinical Trials to Pharmacies Nationwide
What You Should Know:
- Medable and CVS Health announced a strategic collaboration that will make clinical research more accessible to patients of all demographics. Using Medable’s decentralized trial platform available to CVS Health’s thousands of community MinuteClinics nationwide, most people will be within just five minutes of a decentralized clinical trial research site – finally busting the longstanding barrier to research for millions of Americans
- Where applicable, CVS Health will
Read More
Medidata, Parexel Expands Partnership to Enhance Decentralized Clinical Trial Delivery
What You Should Know:
- Medidata, a Dassault Systèmes company and Parexel, a global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health extends their 15-year global strategic partnership. This extension includes gaining access to Medidata’s continued innovations in clinical trial technology solutions with its unified platform, support of decentralized clinical trials (DCTs), the myMedidata patient portal, Sensor
Read More
UBC Partners with Seqster to Advance Patient-Centric Clinical Trials
- UBC, late-stage research and patient support services organization partners with Seqster PDM, Inc. ("Seqster"), a patient-centric healthcare technology company, to provide nationwide health record interoperability with patient engagement.
- UBC will utilize the technology to enable clinical and observational research to transition from traditional site-based studies to decentralized clinical trials (DCTs). Seqster's turnkey white label solution facilitates the rapid move to a fully
Read More
Science 37, physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices
What You Should Know:
- Science 37, a leader in agile clinical trials, and physIQ Inc, a leader in digital medicine, announced their alliance to help researchers use remote biosensors and machine learning to build more robust data sets.
- The partnership will help boost the number of digital biomarkers and generate insights from continuous data streams to indicate the safety and efficacy of new clinical treatments more quickly and objectively.
Read More
Pfizer, BioNTech Launches Clinical Trial for Omicron-Specific COVID-19 Vaccine
What You Should Know:
- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical trial study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age.
- The study will have three cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an Omicron-based vaccine. The study will draw upon some participants from the companies’ Phase 3 COVID-19
Read More
Philips Launches First At-Home, 12-Lead ECG Integrated Solution for Decentralized Clinical Trials
What You Should Know:
- Philips introduced the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
- The solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.
Patient Attrition Issues
Patient attrition is one of the biggest
Read More
Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine
Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place.
As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors. To what extent,
Read More
Alphabet’s Verily + L’Oréal Partner to Advance Precision Skin Health
What You Should Know:
- Today, Alphabet’s Verily, a world leader in personalized medicine, and L’Oréal, the world leader in beauty, joined forces to lead a new era of precision skin health.
- The first-of-its-kind partnership in the beauty industry aims to break down barriers to dermatology care and bring new insights to dermatologists that can help improve health outcomes for the nearly two billion people worldwide with skin issues.
Strategic Partnership Addresses Unmet Need in
Read More
